Growth Metrics

GoodRx Holdings (GDRX) Return on Capital Employed (2020 - 2025)

GoodRx Holdings' Return on Capital Employed history spans 5 years, with the latest figure at 0.05% for Q4 2024.

  • For Q4 2024, Return on Capital Employed rose 7.0% year-over-year to 0.05%; the TTM value through Dec 2024 reached 0.05%, up 7.0%, while the annual FY2024 figure was 0.05%, 7.0% up from the prior year.
  • Return on Capital Employed for Q4 2024 was 0.05% at GoodRx Holdings, up from 0.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.05% in Q4 2024 and bottomed at 0.25% in Q2 2021.
  • The 5-year median for Return on Capital Employed is 0.0% (2023), against an average of 0.05%.
  • The largest annual shift saw Return on Capital Employed rose 27bps in 2022 before it dropped -3bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.19% in 2020, then surged by 105bps to 0.01% in 2021, then plummeted by -87bps to 0.0% in 2022, then plummeted by -1637bps to 0.02% in 2023, then skyrocketed by 398bps to 0.05% in 2024.
  • Per Business Quant, the three most recent readings for GDRX's Return on Capital Employed are 0.05% (Q4 2024), 0.02% (Q3 2024), and 0.02% (Q2 2024).